Actively Recruiting
Pilot Study Evaluating Soursop Tea for Patients with Relapsed or Refractory Acute Myeloid Leukemia and Multiple Myeloma
Led by Roger Strair · Updated on 2026-08-18
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the potential anti-cancer effects and safety of tea made from the dried leaves of Annona muricata soursop in patients with relapsed or refractory acute myeloid leukemia AML or multiple myeloma MM who have no standard treatment options. These blood cancers are aggressive, with poor survival rates especially in older adults, and this pilot study aims to identify any reduction in malignant cell burden from consuming soursop tea. Participants will consume soursop tea over a 21-day period in escalating doses of one, two, and three eight-ounce cups daily, each containing 1.5 grams of dried leaves. The study includes 10 patients with AML and 10 with MM. Patients may remain on study longer if toxicity monitoring requires delays, with only one delay allowed. The use and safety of this biological intervention will be closely observed, and the study will stop if significant irreversible toxicity occurs in more than one participant. Throughout the study, participants will be assessed for leukemia or myeloma burden at the end of treatment and monitored for any tea-related toxicities until resolution. Those continuing soursop tea beyond the initial 21 days will undergo ongoing monitoring for response and safety. Outcome measures include dependent variables tracked from enrollment until the end of treatment. Overall participation spans at least the 21-day treatment, with additional follow-up as needed for safety and response evaluations.
CONDITIONS
Brief Title
A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
Research Team
J
John Riehman-Murphy, RN
R
Roseann Freitag
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here